Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 4Breast Neoplasms 4Myeloproliferative Disorders 3Melanoma 3Skin Neoplasms 2Lung Neoplasms 2Thrombosis 1Pyruvate Kinase Deficiency of Red Cells 1Precancerous Conditions 1Pancreatic Cyst 1Neuroendocrine Tumors 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Myelitis, Transverse 1Myasthenia Gravis 1Multiple Sclerosis 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lymphatic Metastasis 1Locally Advanced Head and Neck Carcinoma 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Esophageal Neoplasms 1Endometrial Neoplasms 1Diagnosis of Cancer of Various Organs 1Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

Radiosurgery 7Temozolomide 6pembrolizumab 4Magnetic Resonance Spectroscopy 4Bevacizumab 4Specimen Handling 3Nivolumab 3abemaciclib 2Watchful Waiting 2Surveys and Questionnaires 2Receptors, Interleukin-8B 2Radiation 2Mental Status and Dementia Tests 2Memantine 2Ipilimumab 2Biopsy 2vorasidenib 1sotorasib 1sapanisertib 1ribociclib 1pertuzumab 1osimertinib 1lenvatinib 1fluciclovine F-18 1entrectinib 1encorafenib 1elacestrant 1dexamethasone acetate 1dexamethasone 21-phosphate 1brivaracetam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Blood Specimen Collection × 30 days × Clear all
NCT07226466 2026-05-22

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

University of California, San Francisco

Not yet recruiting
40 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡